癌症mRNA疫苗:临床应用进展和挑战
Hang Li1, Lang Min2, Haotian Du1
1State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.
Cancer letters
|April 30, 2025
概括
使者RNA (mRNA) 疫苗在癌症治疗方面表现有前途,提供了生产方便和安全性. 本综述涵盖了mRNA癌症疫苗的优化策略,临床进展和挑战,包括个性化新抗原方法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗技术技术 疫苗技术
背景情况:
- 使者RNA (mRNA) 疫苗在免疫疗法中表现出显著的潜力,其在COVID-19大流行期间的成功加速了这一点.
- 已确立的mRNA疫苗的疗效和安全性概况刺激了对其用于癌症治疗的应用的探索.
- 临床前和临床数据表明mRNA技术在瘤学的实质性适用性.
研究的目的:
- 在临床前研究中审查mRNA癌症疫苗的优化策略.
- 总结mRNA癌症疫苗临床试验的进展和挑战.
- 分析各种癌症类型的输送工具,输送方法和应用.
主要方法:
- 关于mRNA癌症疫苗的临床前研究和人类临床试验的综合文献综述.
- 对疫苗设计因素的分析,包括抗原选择,稳定性和输送系统.
- 从临床试验中评估安全性,耐受性和免疫反应数据.
主要成果:
- mRNA疫苗有效诱导特定的抗瘤免疫反应.
- 临床试验表明mRNA癌症疫苗的安全性和耐受性概况良好.
- 个性化新抗原疫苗代表了未来癌症免疫治疗的有希望的方向.
结论:
- mRNA疫苗是癌症治疗的可行和进步的治疗策略.
- 解决抗原选择,稳定性和耐药性的挑战对于进一步发展至关重要.
- 对个性化mRNA疫苗的持续研究具有改善癌症免疫治疗结果的巨大潜力.
相关概念视频
Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Nuclear Export of mRNA
7.5K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.5K
Mouse Models of Cancer Study
5.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.4K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K


